A meta-analysis comparing the diagnostic accuracy of IHC, tumor mutation burden, gene expression profiling, and mIF in predicting a therapeutic response to anti-PD-1/PD-L1 therapy found that mIF showed superior AUC, positive predictive values, and positive likelihood ratios, suggesting an improved performance by mIF compared with traditional methods [85]. The gene discussed is CD274; the disease is neoplasm.